Lenizak 75 mg FC tablet.
PDF Leaflet Revision Date: 26 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of moderate to severe acute pain.
Dosage (summary)
1 tablet every 8 hours, max 3 tablets/day for adults; max 2 tablets/day for elderly.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Other NSAIDs
- Anticoagulants
- MAO inhibitors
- CNS depressants
Contraindications
- Hypersensitivity to components
- Severe hepatic impairment
- Moderate to severe renal impairment
- Active gastrointestinal bleeding
Common side effects
- Nausea
- Dizziness
- Constipation
- Vomiting
Counselling Points
- Take with water 30 mins before meals.
- Do not exceed recommended dose.
- Report any signs of gastrointestinal bleeding.
Serious warnings
- Risk of gastrointestinal bleeding
- Potential for respiratory depression
- Risk of addiction and dependence
Important Disclaimer
The Lenizak 75 mg FC tablet. professional information leaflet below is the property of Menarini South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
